| Document Date: 2014-11-24 08:41:11
Open Document File Size: 95,39 KBShare Result on Facebook
City Seattle / Raleigh / New York / Kankakee / / Company CSL Behring LLC / ViroPharma Incorporated. / Salix Pharmaceuticals Inc. / Hereditary Angioedema International Working Group / Bernstein / / Country United States / / Event Person Communication and Meetings / / Facility American College of Allergy / / IndustryTerm consensus algorithm / treatment of HAE or related disorders / / MedicalCondition abdominal pain / laryngeal edema / HAE / C1 inhibitor deficiency / hereditary angioedema / related disorders / angioedema / angioedema attacks / hereditary C1 inhibitor deficiency / acute angioedema attacks / Asthma / / Organization Food and Drug Administration / the American College / / Person Ann Allergy / Arch Intern / / / Position physician / / Product INH / The medication / / ProvinceOrState Washington / / Technology consensus algorithm / /
SocialTag |
PRIOR AUTHORIZATION POLICY C1 esterase inhibitors Cinryze (C1 esterase inhibitor [human] for intravenous {IV} ViroPharma Biologics) Berinert® (C1 esterase inhibitor [human] for IV CSL Behring) Ruconest® (recombinant C1